Accelerating the transition between preclinical and clinical research
IDMIT has crucial assets to meet the challenges of infectious diseases affecting humans: rare expertise in preclinical and clinical research, laboratories and technological resources, particularly for in vivo imaging, at the cutting edge of innovation for the study of pathogens and host response. In addition to its experience in bioinformatics, genomics and data analysis, Life & Soft brings complementary resources to IDMIT's expertise and technologies: in vivo optical and nuclear imaging, flow cytometry coupled with mass spectrometry. Through this merger, Life & Soft is pursuing its partnership strategy in fundamental research with public bodies and CEA-Jacob is strengthening its links with diagnostics and genomic research as part of its mission on pre-clinical and clinical research on human infectious diseases. The collaboration between the two partners will accelerate the transition from preclinical research to clinical trials, in order to improve the patient care pathway.First results from SARS-Cov 2
The collaboration is already reflected in a common research axis on the SARS-CoV 2 virus, which has been rapidly developed over the last few months in response to the health emergency. It has thus enabled the identification of co-morbidity profiles, thanks to metagenomics and analyses of other biomarkers derived from sequencing, patient viroma and age-related differences in susceptibility. Initial screening tests have been successfully completed and further sequencing is planned. These results were made possible by the complementarity between CEA's infrastructure, adapted to the exploitation of samples, and the use by Life & Soft of nanopore sequencing as a high throughput, rapid and precise analysis method. In this context, Life & Soft's expertise in bioinformatics and biostatistics has also been put to good use and reinforced by the use of artificial intelligence algorithms. Translated from Partenariat Life & Soft et CEA en bio-informatique, génomique, intelligence artificielle et technologies d’imagerie de pointeOur articles will then appear first in Google Top Stories.